Literature DB >> 25465005

Preparation and characterization of vorinostat-coated beads for profiling of novel target proteins.

Congcong Lu1, Kai Zhang2, Yi Zhang3, Minjia Tan3, Yijun Li1, Xiwen He1, Yukui Zhang4.   

Abstract

Inhibitors of histone deacetylases (HDACs) have been considered to be new anticancer agents. As a key inhibitor of HDAC, vorinostat can cause growth arrest and death of a broad of transformed cells and interact with a variety of substrates. A comprehensive analysis of proteins interacting with HDAC inhibitors is of great importance in understanding molecular mechanisms of the drugs. Here, we reported the preparation and characterization of vorinostat-coated beads for profiling of novel target proteins of vorinostat (a key HDAC inhibitor). The enriched proteins were further analyzed by HPLC-MS/MS. Besides the known substrates, there were also several novel enriched protein candidates, one of which was a metalloenzyme α-enolase (ENO-1). According to our best knowledge, it is the first time that ENO-1 has been detected as a potential target of vorinostat through chemoproteomics approach. Further competition analysis indicated that ENO-1 may be co-enriched as a substrate complex. Our results demonstrated that the chemical probe combined with proteomics approach may be developed as a potential tool to identify target proteins of drugs.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemical probe; HPLC–MS/MS; Proteomics; Target proteins; Vorinostat

Year:  2014        PMID: 25465005     DOI: 10.1016/j.chroma.2014.10.098

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  3 in total

1.  Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma.

Authors:  Arghya Ray; Yan Song; Ting Du; Dharminder Chauhan; Kenneth C Anderson
Journal:  Oncogene       Date:  2020-02-05       Impact factor: 9.867

2.  Effects of suberoylanilide hydroxamic acid on rat cytochrome P450 enzyme activities.

Authors:  Kezhi Lin; Qingwei Zhang; Zezheng Liu; Suping Yang; Yingying Lin; Congcong Wen; Yuancai Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 3.  Studying epigenetic complexes and their inhibitors with the proteomics toolbox.

Authors:  David Weigt; Carsten Hopf; Guillaume Médard
Journal:  Clin Epigenetics       Date:  2016-07-18       Impact factor: 6.551

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.